Trial intelligence / Profile preview

N-acetyl cysteine for renal graft function biomarkers after kidney transplantation

IRCT201109067490N1Phase 3Completed

Sponsor
Urology and Nephrology Research Center
Start
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of acetylcysteine in delayed graft function (DGF), sponsored by Urology and Nephrology Research Center. Primary endpoints: Interleukin-18 and Neutrophil gelatinase-associated lipocalin. Started Apr 2011; status: completed.

02

Drugs

acetylcysteine
03

Conditions

delayed graft function (DGF)

Beyond the preview

Go deeper on IRCT201109067490N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201109067490N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call